Xylem Inc (NYSE:XYL) Shares Purchased by Calamos Advisors LLC

Calamos Advisors LLC lifted its holdings in Xylem Inc (NYSE:XYL) by 9.5% in the third quarter, HoldingsChannel reports. The firm owned 88,027 shares of the industrial products company’s stock after buying an additional 7,640 shares during the quarter. Calamos Advisors LLC’s holdings in Xylem were worth $7,009,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Amundi Pioneer Asset Management Inc. boosted its stake in shares of Xylem by 5.5% during the 1st quarter. Amundi Pioneer Asset Management Inc. now owns 1,754,058 shares of the industrial products company’s stock worth $138,641,000 after acquiring an additional 91,397 shares during the last quarter. DNB Asset Management AS boosted its stake in shares of Xylem by 6.7% during the 2nd quarter. DNB Asset Management AS now owns 37,831 shares of the industrial products company’s stock worth $3,164,000 after acquiring an additional 2,387 shares during the last quarter. Norman Fields Gottscho Capital Management LLC purchased a new position in shares of Xylem during the 2nd quarter worth $201,000. Retirement Systems of Alabama boosted its stake in shares of Xylem by 0.4% during the 2nd quarter. Retirement Systems of Alabama now owns 83,912 shares of the industrial products company’s stock worth $7,018,000 after acquiring an additional 305 shares during the last quarter. Finally, Pennsylvania Trust Co boosted its stake in shares of Xylem by 3.3% during the 2nd quarter. Pennsylvania Trust Co now owns 14,150 shares of the industrial products company’s stock worth $1,184,000 after acquiring an additional 450 shares during the last quarter. Hedge funds and other institutional investors own 84.56% of the company’s stock.

XYL has been the topic of several analyst reports. Zacks Investment Research cut shares of Xylem from a “hold” rating to a “sell” rating and set a $82.00 price target on the stock. in a research note on Monday, October 14th. Credit Suisse Group cut shares of Xylem from an “outperform” rating to a “neutral” rating in a research note on Friday, August 2nd. Jefferies Financial Group initiated coverage on shares of Xylem in a research note on Friday, September 20th. They set a “buy” rating and a $90.00 price target on the stock. ValuEngine cut shares of Xylem from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Finally, Seaport Global Securities reiterated a “buy” rating on shares of Xylem in a research note on Tuesday, October 15th. Two analysts have rated the stock with a sell rating, three have given a hold rating and eight have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $80.92.

In other Xylem news, SVP Colin R. Sabol sold 4,099 shares of the business’s stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $78.37, for a total value of $321,238.63. Following the sale, the senior vice president now owns 33,518 shares in the company, valued at approximately $2,626,805.66. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Kenneth Napolitano sold 5,000 shares of the business’s stock in a transaction on Monday, September 9th. The stock was sold at an average price of $77.49, for a total transaction of $387,450.00. Following the completion of the sale, the senior vice president now owns 46,228 shares in the company, valued at approximately $3,582,207.72. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 19,099 shares of company stock worth $1,464,339. 0.85% of the stock is owned by corporate insiders.

XYL opened at $81.27 on Wednesday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.08 and a current ratio of 1.47. Xylem Inc has a fifty-two week low of $60.65 and a fifty-two week high of $85.39. The firm’s fifty day moving average is $77.75 and its 200 day moving average is $78.96. The stock has a market cap of $14.36 billion, a price-to-earnings ratio of 28.22, a price-to-earnings-growth ratio of 1.53 and a beta of 1.19.

Xylem (NYSE:XYL) last released its earnings results on Thursday, August 1st. The industrial products company reported $0.79 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.79. Xylem had a net margin of 10.90% and a return on equity of 19.23%. The company had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.35 billion. During the same quarter in the previous year, the company earned $0.73 EPS. Xylem’s revenue for the quarter was up 2.1% on a year-over-year basis. On average, equities research analysts predict that Xylem Inc will post 3.15 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 5th. Investors of record on Thursday, October 31st will be paid a dividend of $0.24 per share. This represents a $0.96 dividend on an annualized basis and a dividend yield of 1.18%. The ex-dividend date is Wednesday, October 30th. Xylem’s dividend payout ratio (DPR) is 33.33%.

About Xylem

Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.

See Also: Differences Between Momentum Investing and Long Term Investing

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc (NYSE:XYL).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.